Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with sarcoma (a type of cancer) affecting soft tissues or internal organs
- People whose cancer cannot be removed by surgery and has either spread to other parts of the body or has grown significantly in a local area
- People for whom a doctor has recommended treatment with one of the following medicines as a single drug: pazopanib, trabectedine, eribulin, ifosfamide, or dacarbazine
- People who are covered by French social security
- People who have read, understood, and signed a consent form agreeing to take part
Who may not be able to join:
- People who have already taken part in the ePPS trial for a previous cancer treatment
- People who have significant difficulty reading or understanding French
- People who have difficulty accessing or using a computer
- People who are pregnant or currently breastfeeding
- People who are under legal guardianship or whose freedom is restricted by law
- People for whom regular medical follow-up would not be possible due to geographical, social, or psychological reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Diane PANNIER, MD, Centre Oscar Lambret
Phone: 03.20.29.59.59
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Severe toxicity in the first 3 months of treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.